FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(2): 80-82. DOI: 10.12019/j.issn.1671-5144.202410002
|
Citation:
|
FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(2): 80-82. DOI: 10.12019/j.issn.1671-5144.202410002
|
FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(2): 80-82. DOI: 10.12019/j.issn.1671-5144.202410002
|
Citation:
|
FU Rui, WU Yi-long. Reflections on the Failure of the NRG-LU002 Study: Adding Local Therapy to First-Line Immunochemotherapy in Advanced Lung Cancer[J]. Journal of Evidence-Based Medicine, 2025, 25(2): 80-82. DOI: 10.12019/j.issn.1671-5144.202410002
|
DownLoad: